Oncotelic Therapeutics OTLC
OTC OTLC
$0.01 +0.00 (+0.00%)
At close: Nov 6, 2026 · 4:00 PM EST

Oncotelic Therapeutics (OTLC) Net of Acquisitions & Divestments (2019)

Updated

Analysis

Oncotelic Therapeutics (OTLC) Net of Acquisitions & Divestments (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Acquisitions (Qtr)
1 Eli Lilly 1,251.13 Bn 1,224.74 Bn 20.46 Bn -887.00 Mn
2 Johnson & Johnson 677.29 Bn 597.15 Bn 17.30 Bn 17.15 Bn
3 AbbVie 518.44 Bn 486.45 Bn 13.12 Bn -10.59 Bn
4 Merck 364.56 Bn 327.50 Bn 13.19 Bn -630.00 Mn
5 Novartis Ag 316.19 Bn 289.43 Bn - 42.00 Mn
6 Astrazeneca 293.21 Bn 267.11 Bn 13.26 Bn -
7 Amgen 250.58 Bn 202.23 Bn 7.58 Bn -
8 Gilead Sciences 210.08 Bn 185.19 Bn 6.73 Bn -19.00 Mn
9 Pfizer 167.84 Bn 115.19 Bn 12.56 Bn -
10 Oncotelic Therapeutics 7.16 Mn 6.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 6,403.00
API Access

Oncotelic Therapeutics Net of Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-of-acquisitions-and-divestments&ticker=OTLC&period=max&api_key=YOUR_API_KEY